| Year |
Citation |
Score |
| 2022 |
Grosse L, Chouinard S, Pâquet S, Verreault M, Trottier J, Bélanger A, Barbier O. Androgen Glucuronidation in Mice: When, Where, and How. Biology. 11. PMID 35336777 DOI: 10.3390/biology11030403 |
0.552 |
|
| 2017 |
Labrie F, Martel C, Bélanger A, Pelletier G. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology. The Journal of Steroid Biochemistry and Molecular Biology. PMID 28153489 DOI: 10.1016/J.Jsbmb.2016.12.007 |
0.385 |
|
| 2017 |
Labrie F, Bélanger A, Pelletier G, Martel C, Archer DF, Utian WH. Science of intracrinology in postmenopausal women. Menopause (New York, N.Y.). PMID 28098598 DOI: 10.1097/Gme.0000000000000808 |
0.339 |
|
| 2015 |
Gauthier-Landry L, Bélanger A, Barbier O. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution. The Journal of Steroid Biochemistry and Molecular Biology. 145: 187-92. PMID 24861263 DOI: 10.1016/J.Jsbmb.2014.05.009 |
0.607 |
|
| 2013 |
Grosse L, Pâquet S, Caron P, Fazli L, Rennie PS, Bélanger A, Barbier O. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications. Cancer Research. 73: 6963-71. PMID 24121496 DOI: 10.1158/0008-5472.Can-13-1462 |
0.585 |
|
| 2013 |
Ekström L, Cevenini L, Michelini E, Schulze J, Thörngren JO, Belanger A, Guillemette C, Garle M, Roda A, Rane A. Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes. European Journal of Clinical Investigation. 43: 248-55. PMID 23294483 DOI: 10.1111/Eci.12037 |
0.385 |
|
| 2012 |
Labrie F, Simard J, Luu-The V, Bélanger A, Pelletier G. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. The Journal of Steroid Biochemistry and Molecular Biology. 43: 805-26. PMID 22217825 DOI: 10.1016/0960-0760(92)90308-6 |
0.344 |
|
| 2011 |
Olsson M, Ekström L, Guillemette C, Belanger A, Rane A, Gustafsson O. Correlation between circulatory, local prostatic, and intra-prostatic androgen levels. The Prostate. 71: 909-14. PMID 21541968 DOI: 10.1002/Pros.21307 |
0.398 |
|
| 2010 |
Giton F, Caron P, Bérubé R, Bélanger A, Barbier O, Fiet J. Plasma estrone sulfate assay in men: Comparison of radioimmunoassay, mass spectrometry coupled to gas chromatography (GC-MS), and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Clinica Chimica Acta; International Journal of Clinical Chemistry. 411: 1208-13. PMID 20427015 DOI: 10.1016/J.Cca.2010.04.022 |
0.514 |
|
| 2010 |
Christine F, Audet-Walsh É, Bélanger A, Guillemette C. Abstract LB-204: Gene expression profiling of hormone-regulating pathways in tumoral and peritumoral breast tissues Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-204 |
0.375 |
|
| 2008 |
Barbier O, Bélanger A. Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate. Best Practice & Research. Clinical Endocrinology & Metabolism. 22: 259-70. PMID 18471784 DOI: 10.1016/J.Beem.2008.01.001 |
0.651 |
|
| 2008 |
Luu-The V, Bélanger A, Labrie F. Androgen biosynthetic pathways in the human prostate. Best Practice & Research. Clinical Endocrinology & Metabolism. 22: 207-21. PMID 18471780 DOI: 10.1016/J.Beem.2008.01.008 |
0.438 |
|
| 2008 |
Chouinard S, Yueh MF, Tukey RH, Giton F, Fiet J, Pelletier G, Barbier O, Bélanger A. Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. The Journal of Steroid Biochemistry and Molecular Biology. 109: 247-53. PMID 18467088 DOI: 10.1016/J.Jsbmb.2008.03.016 |
0.657 |
|
| 2008 |
Nguyen N, Bonzo JA, Chen S, Chouinard S, Kelner MJ, Hardiman G, Bélanger A, Tukey RH. Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease. The Journal of Biological Chemistry. 283: 7901-11. PMID 18180294 DOI: 10.1074/Jbc.M709244200 |
0.321 |
|
| 2007 |
Chouinard S, Barbier O, Bélanger A. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. The Journal of Biological Chemistry. 282: 33466-74. PMID 17848572 DOI: 10.1074/Jbc.M703370200 |
0.606 |
|
| 2007 |
Shet MS, Fisher CW, Tremblay Y, Belanger A, Conley AJ, Mason JI, Estabrook RW. Comparison of the 17 alpha-hydroxylase/C17,20-lyase activities of porcine, guinea pig and bovine P450c17 using purified recombinant fusion proteins containing P450c17 linked to NADPH-P450 reductase. Drug Metabolism Reviews. 39: 289-307. PMID 17786622 DOI: 10.1080/03602530701468391 |
0.355 |
|
| 2007 |
Swanson C, Lorentzon M, Vandenput L, Labrie F, Rane A, Jakobsson J, Chouinard S, Bélanger A, Ohlsson C. Sex steroid levels and cortical bone size in young men are associated with a uridine diphosphate glucuronosyltransferase 2B7 polymorphism (H268Y). The Journal of Clinical Endocrinology and Metabolism. 92: 3697-704. PMID 17579197 DOI: 10.1210/Jc.2007-0530 |
0.313 |
|
| 2007 |
Caillier B, Lépine J, Tojcic J, Ménard V, Perusse L, Bélanger A, Barbier O, Guillemette C. A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3. Pharmacogenetics and Genomics. 17: 481-95. PMID 17558304 DOI: 10.1097/Fpc.0B013E32806D87A4 |
0.568 |
|
| 2007 |
Bonzo JA, Bélanger A, Tukey RH. The role of chrysin and the ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice. Hepatology (Baltimore, Md.). 45: 349-60. PMID 17256720 DOI: 10.1002/Hep.21481 |
0.333 |
|
| 2007 |
Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J. Metabolism of DHEA in postmenopausal women following percutaneous administration. The Journal of Steroid Biochemistry and Molecular Biology. 103: 178-88. PMID 17084625 DOI: 10.1016/J.Jsbmb.2006.09.034 |
0.327 |
|
| 2007 |
Sancéau J, Larouche D, Caron B, Bélanger P, Coquet A, Bélanger A, Labrie F, Gauthier S. Synthesis and deuterium labelling of the pure selective estrogen receptor modulator (SERM) acolbifene glucuronides Journal of Labelled Compounds and Radiopharmaceuticals. 50: 197-206. DOI: 10.1002/Jlcr.1260 |
0.323 |
|
| 2006 |
Chouinard S, Pelletier G, Bélanger A, Barbier O. Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation. Endocrinology. 147: 5431-42. PMID 16887906 DOI: 10.1210/En.2006-0229 |
0.629 |
|
| 2006 |
Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. The Journal of Steroid Biochemistry and Molecular Biology. 99: 182-8. PMID 16621522 DOI: 10.1016/J.Jsbmb.2006.02.004 |
0.376 |
|
| 2006 |
Thibaudeau J, Lépine J, Tojcic J, Duguay Y, Pelletier G, Plante M, Brisson J, Têtu B, Jacob S, Perusse L, Bélanger A, Guillemette C. Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. Cancer Research. 66: 125-33. PMID 16397224 DOI: 10.1158/0008-5472.Can-05-2857 |
0.365 |
|
| 2005 |
Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G, Labrie C. Is dehydroepiandrosterone a hormone? The Journal of Endocrinology. 187: 169-96. PMID 16293766 DOI: 10.1677/Joe.1.06264 |
0.438 |
|
| 2005 |
Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez J, Candas B. Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocrine Reviews. 26: 361-79. PMID 15867098 DOI: 10.1210/Er.2004-0017 |
0.378 |
|
| 2004 |
Labrie F, Cusan L, Gomez J, Luu-The V, Candas B, Bélanger A, Labrie C. Major impact of hormonal therapy in localized prostate cancer--death can already be an exception. The Journal of Steroid Biochemistry and Molecular Biology. 92: 327-44. PMID 15698538 DOI: 10.1016/J.Jsbmb.2004.10.011 |
0.361 |
|
| 2004 |
Chouinard S, Pelletier G, Bélanger A, Barbier O. Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium. Endocrine Research. 30: 717-25. PMID 15666817 DOI: 10.1081/Erc-200044014 |
0.644 |
|
| 2004 |
Guillemette C, Bélanger A, Lépine J. Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Research : Bcr. 6: 246-54. PMID 15535854 DOI: 10.1186/Bcr936 |
0.35 |
|
| 2004 |
Leblanc M, Bélanger MC, Julien P, Tchernof A, Labrie C, Bélanger A, Labrie F. Plasma lipoprotein profile in the male cynomolgus monkey under normal, hypogonadal, and combined androgen blockade conditions. The Journal of Clinical Endocrinology and Metabolism. 89: 1849-57. PMID 15070955 DOI: 10.1210/Jc.2003-031233 |
0.348 |
|
| 2004 |
Martineau I, Tchernof A, Bélanger A. Amino acid residue ILE211 is essential for the enzymatic activity of human UDP-glucuronosyltransferase 1A10 (UGT1A10). Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 455-9. PMID 15039300 DOI: 10.1124/Dmd.32.4.455 |
0.769 |
|
| 2003 |
Bélanger A, Pelletier G, Labrie F, Barbier O, Chouinard S. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends in Endocrinology and Metabolism: Tem. 14: 473-9. PMID 14643063 DOI: 10.1016/J.Tem.2003.10.005 |
0.63 |
|
| 2003 |
Bélanger A. [Inactivation of androgens by UDP-glucuronosyltransferases]. MéDecine Sciences : M/S. 19: 931-6. PMID 14613002 DOI: 10.1051/Medsci/20031910931 |
0.415 |
|
| 2003 |
Martineau I, Bélanger A, Tchernof A, Tremblay Y. Molecular cloning and expression of guinea pig cytochrome P450c21 cDNA (steroid 21-hydroxylase) isolated from the adrenals. The Journal of Steroid Biochemistry and Molecular Biology. 86: 123-32. PMID 14568563 DOI: 10.1016/S0960-0760(03)00261-9 |
0.791 |
|
| 2003 |
Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey. The Journal of Clinical Endocrinology and Metabolism. 88: 4293-302. PMID 12970301 DOI: 10.1210/Jc.2003-022012 |
0.401 |
|
| 2003 |
Barbier O, Bélanger A. The cynomolgus monkey (Macaca fascicularis) is the best animal model for the study of steroid glucuronidation. The Journal of Steroid Biochemistry and Molecular Biology. 85: 235-45. PMID 12943709 DOI: 10.1016/S0960-0760(03)00235-8 |
0.648 |
|
| 2003 |
Dimitrakakis C, Zhou J, Wang J, Belanger A, LaBrie F, Cheng C, Powell D, Bondy C. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause (New York, N.Y.). 10: 292-8. PMID 12851512 DOI: 10.1097/01.Gme.0000055522.67459.89 |
0.328 |
|
| 2003 |
Girard C, Barbier O, Veilleux G, El-Alfy M, Bélanger A. Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites. Endocrinology. 144: 2659-68. PMID 12746330 DOI: 10.1210/En.2002-0052 |
0.628 |
|
| 2003 |
Labrie F, Luu-The V, Labrie C, Bélanger A, Simard J, Lin SX, Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrine Reviews. 24: 152-82. PMID 12700178 DOI: 10.1210/Er.2001-0031 |
0.439 |
|
| 2003 |
Turgeon D, Carrier JS, Chouinard S, Bélanger A. Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 670-6. PMID 12695357 DOI: 10.1124/Dmd.31.5.670 |
0.746 |
|
| 2003 |
Turgeon D, Chouinard S, Belanger P, Picard S, Labbe JF, Borgeat P, Belanger A. Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases. Journal of Lipid Research. 44: 1182-91. PMID 12639971 DOI: 10.1194/Jlr.M300010-Jlr200 |
0.753 |
|
| 2002 |
Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey. The Journal of Steroid Biochemistry and Molecular Biology. 81: 159-64. PMID 12137806 DOI: 10.1016/S0960-0760(02)00059-6 |
0.399 |
|
| 2002 |
Girard C, Barbier O, Turgeon D, Bélanger A. Isolation and characterization of the monkey UGT2B30 gene that encodes a uridine diphosphate-glucuronosyltransferase enzyme active on mineralocorticoid, glucocorticoid, androgen and oestrogen hormones. The Biochemical Journal. 365: 213-22. PMID 12071853 DOI: 10.1042/Bj20011594 |
0.817 |
|
| 2001 |
Labrie F, Labrie C, Bélanger A, Simard J, Giguère V, Tremblay A, Tremblay G. EM-652 (SCH57068), a pure SERM having complete antiestrogenic activity in the mammary gland and endometrium. The Journal of Steroid Biochemistry and Molecular Biology. 79: 213-225. PMID 11850228 DOI: 10.1016/S0960-0760(01)00139-X |
0.346 |
|
| 2001 |
Pelletier G, Li S, Luu-The V, Tremblay Y, Bélanger A, Labrie F. Immunoelectron microscopic localization of three key steroidogenic enzymes (cytochrome P450(scc), 3 beta-hydroxysteroid dehydrogenase and cytochrome P450(c17)) in rat adrenal cortex and gonads. The Journal of Endocrinology. 171: 373-83. PMID 11691658 DOI: 10.1677/Joe.0.1710373 |
0.364 |
|
| 2001 |
Vallée M, Albert C, Beaudry G, Hum DW, Bélanger A. Isolation and characterization of the monkey UDP-glucuronosyltransferase cDNA clone monUGT1A01 active on bilirubin and estrogens. The Journal of Steroid Biochemistry and Molecular Biology. 77: 239-49. PMID 11457662 DOI: 10.1016/S0960-0760(01)00062-0 |
0.793 |
|
| 2001 |
Labrie F, Labrie C, Bélanger A, Giguere V, Simard J, Mérand Y, Gauthier S, Luu-The V, Candas B, Martel C, Luo S. Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities. Advances in Protein Chemistry. 56: 293-368. PMID 11329857 DOI: 10.1016/S0065-3233(01)56009-X |
0.359 |
|
| 2001 |
Lévesque E, Turgeon D, Carrier JS, Montminy V, Beaulieu M, Bélanger A. Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry. 40: 3869-81. PMID 11300766 DOI: 10.1021/Bi002607Y |
0.755 |
|
| 2001 |
Barbier O, Albert C, Martineau I, Vallée M, High K, Labrie F, Hum DW, Labrie C, Bélanger A. Glucuronidation of the nonsteroidal antiestrogen EM-652 (SCH 57068), by human and monkey steroid conjugating UDP-glucuronosyltransferase enzymes. Molecular Pharmacology. 59: 636-45. PMID 11179460 DOI: 10.1124/Mol.59.3.636 |
0.784 |
|
| 2001 |
Turgeon D, Carrier JS, Lévesque E, Hum DW, Bélanger A. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology. 142: 778-87. PMID 11159850 DOI: 10.1210/Endo.142.2.7958 |
0.798 |
|
| 2000 |
Barbier O, Lapointe H, El Alfy M, Hum DW, Bélanger A. Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry. The Journal of Clinical Endocrinology and Metabolism. 85: 4819-26. PMID 11134149 DOI: 10.1210/Jcem.85.12.7019 |
0.611 |
|
| 2000 |
Mauriège P, Langin D, Montminy V, Martel C, Després J, Bélanger A, Labrie F, Deshaies Y. Effect of a long-term percutaneous adrenal steroid treatment on rat adipose tissue metabolism. International Journal of Obesity. 24. PMID 10997639 DOI: 10.1038/Sj.Ijo.0801308 |
0.308 |
|
| 2000 |
Barbier O, Girard C, Breton R, Bélanger A, Hum DW. N-glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltransferase enzymes. Biochemistry. 39: 11540-52. PMID 10995221 DOI: 10.1021/Bi000779P |
0.539 |
|
| 2000 |
Picard F, Deshaies Y, Lalonde J, Samson P, Labrie C, Bélanger A, Labrie F, Richard D. Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats International Journal of Obesity. 24: 830-840. PMID 10918529 DOI: 10.1038/Sj.Ijo.0801240 |
0.334 |
|
| 2000 |
Labrie F, Luu-The V, Lin SX, Simard J, Labrie C, El-Alfy M, Pelletier G, Bélanger A. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. Journal of Molecular Endocrinology. 25: 1-16. PMID 10915214 DOI: 10.1677/Jme.0.0250001 |
0.376 |
|
| 2000 |
Carrier JS, Turgeon D, Journault K, Hum DW, Bélanger A. Isolation and characterization of the human UGT2B7 gene. Biochemical and Biophysical Research Communications. 272: 616-21. PMID 10833461 DOI: 10.1006/Bbrc.2000.2795 |
0.747 |
|
| 2000 |
Turgeon D, Carrier JS, Lévesque E, Beatty BG, Bélanger A, Hum DW. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. Journal of Molecular Biology. 295: 489-504. PMID 10623541 DOI: 10.1006/Jmbi.1999.3374 |
0.719 |
|
| 1999 |
Tchernof A, Lévesque E, Beaulieu M, Couture P, Després JP, Hum DW, Bélanger A. Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method. Clinical Endocrinology. 50: 637-42. PMID 10468930 DOI: 10.1046/J.1365-2265.1999.00709.X |
0.435 |
|
| 1999 |
Hum DW, Bélanger A, Lévesque E, Barbier O, Beaulieu M, Albert C, Vallée M, Guillemette C, Tchernof A, Turgeon D, Dubois S. Characterization of UDP-glucuronosyltransferases active on steroid hormones. The Journal of Steroid Biochemistry and Molecular Biology. 69: 413-23. PMID 10419020 DOI: 10.1016/S0960-0760(99)00061-8 |
0.819 |
|
| 1999 |
Labrie F, Labrie C, Bélanger A, Simard J, Gauthier S, Luu-The V, Mérand Y, Giguere V, Candas B, Luo S, Martel C, Singh SM, Fournier M, Coquet A, Richard V, et al. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. The Journal of Steroid Biochemistry and Molecular Biology. 69: 51-84. PMID 10418981 DOI: 10.1016/S0960-0760(99)00065-5 |
0.376 |
|
| 1999 |
Albert C, Vallée M, Beaudry G, Bélanger A, Hum DW. The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes. Endocrinology. 140: 3292-302. PMID 10385426 DOI: 10.1210/Endo.140.7.6853 |
0.793 |
|
| 1999 |
Bélanger G, Barbier O, Hum DW, Bélanger A. Molecular cloning, expression and characterization of a monkey steroid UDP-glucuronosyltransferase, UGT2B19, that conjugates testosterone. European Journal of Biochemistry / Febs. 260: 701-8. PMID 10102998 DOI: 10.1046/J.1432-1327.1999.00197.X |
0.637 |
|
| 1999 |
Labrie F, Candas B, Dupont A, Cusan L, Gomez JL, Suburu RE, Diamond P, Lévesque J, Belanger A. Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. The Prostate. 38: 83-91. PMID 9973093 DOI: 10.1002/(Sici)1097-0045(19990201)38:2<83::Aid-Pros1>3.0.Co;2-B |
0.326 |
|
| 1999 |
BARBIER O, BÉLANGER A, HUM DW. Cloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C19 steroid-conjugating protein Biochemical Journal. 337: 567. DOI: 10.1042/Bj3370567 |
0.678 |
|
| 1998 |
Beaudoin C, Lavallée B, Tremblay Y, Hum DW, Breton R, de Launoit Y, Bélanger A. Modulation of 17alpha-hydroxylase/17,20-lyase activity of guinea pig cytochrome P450c17 by site-directed mutagenesis. Dna and Cell Biology. 17: 707-15. PMID 9726253 DOI: 10.1089/Dna.1998.17.707 |
0.414 |
|
| 1998 |
Sourla A, Flamand M, Bélanger A, Labrie F. Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat. The Journal of Steroid Biochemistry and Molecular Biology. 66: 137-49. PMID 9719448 DOI: 10.1016/S0960-0760(98)00052-1 |
0.346 |
|
| 1998 |
Bélanger A, Hum DW, Beaulieu M, Lévesque E, Guillemette C, Tchernof A, Bélanger G, Turgeon D, Dubois S. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. The Journal of Steroid Biochemistry and Molecular Biology. 65: 301-10. PMID 9699884 DOI: 10.1016/S0960-0760(97)00183-0 |
0.797 |
|
| 1998 |
Beaulieu M, Lévesque E, Hum DW, Bélanger A. Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochemical and Biophysical Research Communications. 248: 44-50. PMID 9675083 DOI: 10.1006/Bbrc.1998.8908 |
0.374 |
|
| 1998 |
Lévesque E, Beaulieu M, Guillemette C, Hum DW, Bélanger A. Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line. The Journal of Steroid Biochemistry and Molecular Biology. 64: 43-8. PMID 9569009 DOI: 10.1016/S0960-0760(97)00137-4 |
0.416 |
|
| 1998 |
Luo S, Sourla A, Labrie C, Gauthier S, Merand Y, Belanger A, Labrie F. Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice. Endocrinology. 139: 2645-56. PMID 9564882 DOI: 10.1210/Endo.139.5.5994 |
0.335 |
|
| 1998 |
Beaulieu M, Lévesque E, Barbier O, Turgeon D, Bélanger G, Hum DW, Bélanger A. Isolation and characterization of a simian UDP-glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogens. Journal of Molecular Biology. 275: 785-94. PMID 9480769 DOI: 10.1006/Jmbi.1997.1486 |
0.8 |
|
| 1997 |
Luo S, Martel C, Gauthier S, Mérand Y, Bélanger A, Labrie C, Labrie F. Long-term inhibitory effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice. International Journal of Cancer. 73: 735-9. PMID 9398055 DOI: 10.1002/(Sici)1097-0215(19971127)73:5<735::Aid-Ijc21>3.0.Co;2-3 |
0.314 |
|
| 1997 |
Bélanger G, Beaulieu M, Lévesque E, Hum DW, Bélanger A. Expression and characterization of a novel UDP-glucuronosyltransferase, UGT2B9, from cynomolgus monkey. Dna and Cell Biology. 16: 1195-205. PMID 9364930 DOI: 10.1089/Dna.1997.16.1195 |
0.51 |
|
| 1997 |
Beaulieu M, Lévesque E, Tchernof A, Beatty BG, Bélanger A, Hum DW. Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. Dna and Cell Biology. 16: 1143-54. PMID 9364925 DOI: 10.1089/Dna.1997.16.1143 |
0.469 |
|
| 1997 |
Luo S, Martel C, Sourla A, Gauthier S, Mérand Y, Belanger A, Labrie C, Labrie F. Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice. International Journal of Cancer. 73: 381-91. PMID 9359486 DOI: 10.1002/(Sici)1097-0215(19971104)73:3<381::Aid-Ijc13>3.0.Co;2-G |
0.366 |
|
| 1997 |
Simard J, Labrie C, Bélanger A, Gauthier S, Singh SM, Mérand Y, Labrie F. Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro. International Journal of Cancer. 73: 104-12. PMID 9334816 DOI: 10.1002/(Sici)1097-0215(19970926)73:1<104::Aid-Ijc16>3.0.Co;2-G |
0.347 |
|
| 1997 |
Tchernof A, Labrie F, Bélanger A, Prud'homme D, Bouchard C, Tremblay A, Nadeau A, Després JP. Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables. Atherosclerosis. 133: 235-44. PMID 9298684 DOI: 10.1016/S0021-9150(97)00125-1 |
0.327 |
|
| 1997 |
Lévesque E, Beaulieu M, Green MD, Tephly TR, Bélanger A, Hum DW. Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics. 7: 317-25. PMID 9295060 DOI: 10.1097/00008571-199708000-00007 |
0.476 |
|
| 1997 |
Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Bélanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 7: 255-69. PMID 9295054 DOI: 10.1097/00008571-199708000-00001 |
0.323 |
|
| 1997 |
Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R, Bélanger A. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids. 62: 148-58. PMID 9029730 DOI: 10.1016/S0039-128X(96)00174-2 |
0.322 |
|
| 1996 |
Beaulieu M, Lévesque E, Hum DW, Bélanger A. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. The Journal of Biological Chemistry. 271: 22855-62. PMID 8798464 DOI: 10.1074/Jbc.271.37.22855 |
0.408 |
|
| 1996 |
Guillemette C, Hum DW, Bélanger A. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line. Endocrinology. 137: 2872-9. PMID 8770908 DOI: 10.1210/Endo.137.7.8770908 |
0.38 |
|
| 1996 |
Guillemette C, Hum DW, Bélanger A. Levels of plasma C19 steroids and 5 alpha-reduced C19 steroid glucuronides in primates, rodents, and domestic animals. The American Journal of Physiology. 271: E348-53. PMID 8770030 DOI: 10.1152/Ajpendo.1996.271.2.E348 |
0.331 |
|
| 1996 |
Dufort I, Tremblay Y, Bélanger A, Labrie F, Luu-The V. Isolation and characterization of a stereospecific 3beta-hydroxysteriod sulfotransferase (pregnenolone sulfotransferase) cDNA. Dna and Cell Biology. 15: 481-7. PMID 8672244 DOI: 10.1089/Dna.1996.15.481 |
0.441 |
|
| 1996 |
Guillemette C, Hum DW, Bélanger A. Evidence for a role of glucuronosyltransferase in the regulation of androgen action in the human prostatic cancer cell line LNCaP. The Journal of Steroid Biochemistry and Molecular Biology. 57: 225-31. PMID 8645632 DOI: 10.1016/0960-0760(95)00258-8 |
0.373 |
|
| 1996 |
Labrie C, Flamand M, Bélanger A, Labrie F. High bioavailability of dehydroepiandrosterone administered percutaneously in the rat. Journal of Endocrinology. 150. DOI: 10.1677/Joe.0.150S107 |
0.389 |
|
| 1995 |
Bélanger G, Beaulieu M, Marcotte B, Lévesque E, Guillemette C, Hum DW, Bélanger A. Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line. Molecular and Cellular Endocrinology. 113: 165-73. PMID 8674824 DOI: 10.1016/0303-7207(95)03627-J |
0.499 |
|
| 1995 |
Labrie F, Bélanger A, Simard J, Van Luu-The, Labrie C. DHEA and peripheral androgen and estrogen formation: intracinology. Annals of the New York Academy of Sciences. 774: 16-28. PMID 8597456 DOI: 10.1111/J.1749-6632.1995.Tb17369.X |
0.342 |
|
| 1995 |
Tremblay Y, Fleury A, Beaudoin C, Vallée M, Bélanger A. Molecular cloning and expression of guinea pig cytochrome P450c17 cDNA (steroid 17 alpha-hydroxylase/17,20 lyase): tissue distribution, regulation, and substrate specificity of the expressed enzyme. Dna and Cell Biology. 13: 1199-212. PMID 7811386 DOI: 10.1089/Dna.1994.13.1199 |
0.461 |
|
| 1995 |
Guillemette C, Bélanger A. Glucuronosyltransferase activity in human cancer cell line LNCaP. Molecular and Cellular Endocrinology. 107: 131-9. PMID 7768324 DOI: 10.1016/0303-7207(94)03434-U |
0.38 |
|
| 1995 |
Vallée M, Perron S, Tremblay Y, Bélanger A. Regulation of guinea pig adrenal P450c21 messenger RNA, protein and activity by RU486. The Journal of Steroid Biochemistry and Molecular Biology. 54: 31-8. PMID 7632612 DOI: 10.1016/0960-0760(95)00059-9 |
0.386 |
|
| 1995 |
Tremblay Y, Bélanger A, Fleury A, Beaudoin C, Provost P, Martineau I. Studies of the guinea pig adrenal cytochrome P450c17 cDNA. Endocrine Research. 21: 495-507. PMID 7588415 DOI: 10.3109/07435809509030467 |
0.787 |
|
| 1995 |
Bélanger A, Tremblay Y, Vallée M, Provencher PH, Perron S. Regulation of 21-hydroxylase activity by steroids. Endocrine Research. 21: 329-41. PMID 7588396 DOI: 10.3109/07435809509030449 |
0.433 |
|
| 1995 |
Bélanger A, van Halbeek H, Graves HC, Grandbois K, Stamey TA, Huang L, Poppe I, Labrie F. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. The Prostate. 27: 187-97. PMID 7479385 DOI: 10.1002/Pros.2990270403 |
0.334 |
|
| 1994 |
Labrie F, Simard J, Luu-The V, Pelletier G, Belghmi K, Bélanger A. Structure, regulation and role of 3 beta-hydroxysteroid dehydrogenase, 17 beta-hydroxysteroid dehydrogenase and aromatase enzymes in the formation of sex steroids in classical and peripheral intracrine tissues. Bailliere's Clinical Endocrinology and Metabolism. 8: 451-74. PMID 8092980 DOI: 10.1016/S0950-351X(05)80261-7 |
0.391 |
|
| 1994 |
Perron S, Bélanger A. Effects of 4-MA, a potent inhibitor of 5 alpha-reductase, on 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase activity in guinea pig adrenals. Steroids. 59: 371-6. PMID 7940615 DOI: 10.1016/0039-128X(94)90004-3 |
0.368 |
|
| 1993 |
Martel C, Trudel C, Couet J, Labrie C, Bélanger A, Labrie F. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA. Molecular and Cellular Endocrinology. 91: 43-9. PMID 8472853 DOI: 10.1016/0303-7207(93)90253-G |
0.452 |
|
| 1993 |
Labrie F, Belanger A, Simard J, Labrie C, Dupont A. Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy. Cancer. 71: 1059-67. PMID 8428328 DOI: 10.1002/1097-0142(19930201)71:3+<1059::Aid-Cncr2820711426>3.0.Co;2-6 |
0.389 |
|
| 1993 |
Bélanger B, Roy R, Bélanger A. Administration of pregnenolone and dehydroepiandrosterone to guinea pigs and rats causes the accumulation of fatty acid esters of pregnenolone and dehydroepiandrosterone in plasma lipoproteins. Steroids. 57: 430-6. PMID 1455461 DOI: 10.1016/0039-128X(92)90096-R |
0.324 |
|
| 1992 |
Provencher PH, Tremblay Y, Bélanger B, Bélanger A. Steroidogenesis in guinea pig adrenal cortex: effects of ACTH on steroid secretion and steroidogenic enzyme activities and expression. The Journal of Steroid Biochemistry and Molecular Biology. 43: 855-862. PMID 22217829 DOI: 10.1016/0960-0760(92)90312-7 |
0.409 |
|
| 1992 |
Bélanger B, Caron S, Boudou P, Fiet J, Bélanger A. Adrenal steroidogenesis in the guinea pig: effects of androgens. Steroids. 57: 76-81. PMID 1621260 DOI: 10.1016/0039-128X(92)90033-6 |
0.371 |
|
| 1992 |
Roy R, Dauvois S, Labrie F, Belanger A. Estrogen-stimulated glucuronidation of dihydrotestosterone in MCF-7 human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 41: 579-82. PMID 1562529 DOI: 10.1016/0960-0760(92)90387-X |
0.389 |
|
| 1992 |
Pelletier G, Dupont E, Simard J, Luu-The V, Bélanger A, Labrie F. Ontogeny and subcellular localization of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) in the human and rat adrenal, ovary and testis. The Journal of Steroid Biochemistry and Molecular Biology. 43: 451-67. PMID 1390295 DOI: 10.1016/0960-0760(92)90084-V |
0.363 |
|
| 1992 |
Provencher PH, Tremblay Y, Bélanger B, Bélanger A. Studies of adrenal steroidogenic enzymes in guinea pigs. The American Journal of Physiology. 262: E869-74. PMID 1319681 DOI: 10.1152/Ajpendo.1992.262.6.E869 |
0.322 |
|
| 1992 |
Provencher PH, Tremblay Y, Bélanger A. Effects of C19 steroids on adrenal steroidogenic enzyme activities and their mRNA levels in guinea-pig fasciculata-glomerulosa cells in primary culture. The Journal of Endocrinology. 132: 269-76. PMID 1311748 DOI: 10.1677/Joe.0.1320269 |
0.408 |
|
| 1992 |
Provencher PH, Tremblay Y, Caron S, Belanger A. Effect of chronic ACTH treatment on guinea-pig adrenal steroidogenesis: steroid plasma levels, steroid adrenal levels, activity of steroidogenic enzymes and their steady-state mRNA levels. The Journal of Steroid Biochemistry and Molecular Biology. 41: 69-78. PMID 1310416 DOI: 10.1016/0960-0760(92)90226-9 |
0.412 |
|
| 1992 |
Provencher PH, Tremblay Y, Fiet J, Belanger A. Effect of ACTH on steroidogenic enzymes in guinea pig fasciculata-glomerulosa cells: changes in activity and mRNA levels. The Journal of Steroid Biochemistry and Molecular Biology. 41: 59-67. PMID 1310415 DOI: 10.1016/0960-0760(92)90225-8 |
0.411 |
|
| 1991 |
Bélanger A, Brochu M, Lacoste D, Noël C, Labrie F, Dupont A, Cusan L, Caron S, Couture J. Steroid glucuronides: Human circulatory levels and formation by LNCaP cells The Journal of Steroid Biochemistry and Molecular Biology. 40: 593-598. PMID 1835648 DOI: 10.1016/0960-0760(91)90281-9 |
0.372 |
|
| 1991 |
Provencher PH, Bélanger A, Fiet J. Effects of RU 486 on adrenal steroidogenesis in the guinea-pig. The Journal of Endocrinology. 130: 71-8. PMID 1652615 DOI: 10.1677/joe.0.1300071 |
0.302 |
|
| 1990 |
Lacoste D, Dubé D, Trudel C, Bélanger A, Labrie F. Normal gonadal functions and fertility after 23 months of treatment of prepubertal male and female dogs with the GnRh agonist [D-Trp6, des-Gly-NH2(10)]GnRH ethylamide. Journal of Andrology. 10: 456-65. PMID 2695507 DOI: 10.1002/J.1939-4640.1989.Tb00140.X |
0.392 |
|
| 1990 |
Lacoste D, Labrie F, Dubé D, Bélanger A, Tice T, Gilley RM, Pledger KL. Reversible inhibition of testicular androgen secretion by 3-, 5- and 6-month controlled-release microsphere formulations of the LH-RH agonist [D-Trp6, des-Gly-NH10(2)] LH-RH ethylamide in the dog. Journal of Steroid Biochemistry. 33: 1007-11. PMID 2689791 DOI: 10.1016/0022-4731(89)90253-7 |
0.322 |
|
| 1990 |
Roy R, Bélanger A. Lipoproteins: carriers of dehydroepiandrosterone fatty acid esters in human serum. Journal of Steroid Biochemistry. 34: 559-61. PMID 2533952 DOI: 10.1016/0022-4731(89)90145-3 |
0.322 |
|
| 1990 |
Bélanger A, Couture J, Caron S, Roy R. Determination of nonconjugated and conjugated steroid levels in plasma and prostate after separation on C-18 columns. Annals of the New York Academy of Sciences. 595: 251-9. PMID 2375607 DOI: 10.1111/J.1749-6632.1990.Tb34299.X |
0.386 |
|
| 1990 |
Bélanger A, Labrie F, Angeli A. Unconjugated and glucuronide steroid levels in human breast cyst fluid. Annals of the New York Academy of Sciences. 586: 93-100. PMID 2357014 DOI: 10.1111/J.1749-6632.1990.Tb17795.X |
0.383 |
|
| 1990 |
Poulin R, Poirier D, Thériault C, Couture J, Bélanger A, Labrie F. Wide spectrum of steroids serving as substrates for the formation of lipoidal derivatives in ZR-75-1 human breast cancer cells. Journal of Steroid Biochemistry. 35: 237-47. PMID 2308338 DOI: 10.1016/0022-4731(90)90280-6 |
0.423 |
|
| 1990 |
Cusan L, Dupont A, Bélanger A, Tremblay RR, Manhes G, Labrie F. Treatment of hirsutism with the pure antiandrogen flutamide. Journal of the American Academy of Dermatology. 23: 462-9. PMID 2212145 DOI: 10.1016/0190-9622(90)70241-9 |
0.305 |
|
| 1990 |
Bélanger B, Couture J, Caron S, Bodou P, Fiet J, Bélanger A. Production and secretion of C-19 steroids by rat and guinea pig adrenals. Steroids. 55: 360-365. PMID 2173170 DOI: 10.1016/0039-128X(90)90060-O |
0.313 |
|
| 1990 |
Bélanger A, Caron S, Labrie F, Naldoni C, Dogliotti L, Angeli A. Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: relationships with cyst type. European Journal of Cancer (Oxford, England : 1990). 26: 277-81. PMID 2141484 DOI: 10.1016/0277-5379(90)90222-F |
0.342 |
|
| 1990 |
Bélanger B, Bélanger A, Caron S. Presence of Nonpolar Derivatives of Steroids in Bovine, Rat and Guinea Pig Adrenals and Effect of ACTH on Lipoidal Derivatives of Pregnenolone Annals of the New York Academy of Sciences. 595: 447-450. DOI: 10.1111/J.1749-6632.1990.Tb34331.X |
0.306 |
|
| 1990 |
Labrie C, Simard J, Zhao H, Bélanger A, Pelletier G, Labrie F. Stimulation of Androgen-Dependent Gene Expression by the Adrenal Precursors Dehydroepiandrosterone and Androstenedione in the Rat Ventral Prostate Annals of the New York Academy of Sciences. 595: 395-398. DOI: 10.1111/J.1749-6632.1990.Tb34315.X |
0.381 |
|
| 1990 |
Labrie C, Simard J, Poulin M, Bélanger A, Pelletier G, Labrie F. Influence of the Duration of Androgen Deprivation on the Sensitivity of the Rat Ventral Prostate to Dehydroepiandrosterone and Androstenedione Annals of the New York Academy of Sciences. 595: 392-394. DOI: 10.1111/J.1749-6632.1990.Tb34314.X |
0.349 |
|
| 1990 |
Lacoste D, Bélanger A, Labrie F. Biosynthesis and Degradation of Androgens in Human Prostatic Cancer Cell Lines Annals of the New York Academy of Sciences. 595: 389-391. DOI: 10.1111/J.1749-6632.1990.Tb34313.X |
0.391 |
|
| 1990 |
Dupont A, Dupont P, Belanger A, Mailoux J, Cusan L, Labrie F. Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH210]LH-RH ethylamide Fertility and Sterility. 54: 227-232. DOI: 10.1016/S0015-0282(16)53694-2 |
0.303 |
|
| 1989 |
Prévost J, Bélanger A, Bernard C, Lambert RD. Androgen metabolites in bovine follicular fluid. Theriogenology. 31: 675-81. PMID 16726584 DOI: 10.1016/0093-691X(89)90250-1 |
0.38 |
|
| 1989 |
Spinola PG, Marchetti B, Mérand Y, Bélanger A, Labrie F. Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors. Breast Cancer Research and Treatment. 12: 287-96. PMID 3147727 DOI: 10.1007/Bf01811241 |
0.311 |
|
| 1989 |
Dugré FJ, Lambert RD, Bélanger A, Fortier MA, Caron S. Local effect of the rabbit embryo-foetus on uterine progesterone and pregnenolone levels Molecular and Cellular Endocrinology. 64: 251-255. PMID 2792565 DOI: 10.1016/0303-7207(89)90152-4 |
0.31 |
|
| 1989 |
Roy R, Bélanger A. Formation of lipoidal steroids in follicular fluid. Journal of Steroid Biochemistry. 33: 257-62. PMID 2770299 DOI: 10.1016/0022-4731(89)90302-6 |
0.309 |
|
| 1989 |
Labrie F, Dupont A, Bélanger A, Cusan L, Brochu M, Turina E, Pinault S, Lacourciere Y, Emond J. Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapy. British Journal of Urology. 63: 634-8. PMID 2752257 DOI: 10.1111/J.1464-410X.1989.Tb05260.X |
0.335 |
|
| 1989 |
Labrie F, Dupont A, Cusan L, Manhès G, Bergeron N, Lacourcière Y, Pineault S, Bélanger A, Monfette G, Emond J. Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer. Journal of Steroid Biochemistry. 33: 817-21. PMID 2689788 DOI: 10.1016/0022-4731(89)90499-8 |
0.332 |
|
| 1989 |
Lacoste D, Caron S, Bélanger A, Labrie F. Effect of 3-week treatment with [D-Trp6, des-Gly-NH10(2)]LHRH ethylamide, aminoglutethimide, ketoconazole or flutamide alone or in combination on testicular, serum, adrenal and prostatic steroid levels in the dog. Journal of Steroid Biochemistry. 33: 233-42. PMID 2671505 DOI: 10.1016/0022-4731(89)90299-9 |
0.399 |
|
| 1989 |
Bélanger A, Locong A, Noel C, Cusan L, Dupont A, Prévost J, Caron S, Sévigny J. Influence of diet on plasma steroid and sex plasma binding globulin levels in adult men Journal of Steroid Biochemistry. 32: 829-833. PMID 2526906 DOI: 10.1016/0022-4731(89)90459-7 |
0.343 |
|
| 1989 |
Bélanger B, Bélanger A, Labrie F, Dupont A, Cusan L, Monfette G. Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. Journal of Steroid Biochemistry. 32: 695-8. PMID 2525654 DOI: 10.1016/0022-4731(89)90514-1 |
0.402 |
|
| 1989 |
Labrie C, Simard J, Zhao HF, Belanger A, Pelletier G, Labrie F. Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology. 124: 2745-54. PMID 2524377 DOI: 10.1210/Endo-124-6-2745 |
0.436 |
|
| 1988 |
Luthy I, Caron S, Bélanger A, Labrie F. Effects of flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 1: 151-68. PMID 3503483 DOI: 10.3109/09513598709030679 |
0.345 |
|
| 1988 |
Prévost J, Bélanger A. Formation of estrogen glucuronides by human granulosa-luteal cells isolated from human menopausal gonadotropin-stimulated cycles for in vitro fertilization. Biology of Reproduction. 38: 975-9. PMID 3408786 DOI: 10.1095/Biolreprod38.5.975 |
0.391 |
|
| 1988 |
Labrie F, Dupont A, Cusan L, Giguere M, Bergeron N, Borsanyi JP, Lacourciere Y, Belanger A, Emond J, Monfette G. Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice. Journal of Steroid Biochemistry. 30: 107-17. PMID 3290578 DOI: 10.1016/0022-4731(88)90083-0 |
0.337 |
|
| 1988 |
Dupont A, Labrie F, Giguere M, Borsanyi JP, Lacourciere Y, Bergeron N, Cusan L, Belanger A, Emond J. Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinoma. European Journal of Cancer & Clinical Oncology. 24: 659-66. PMID 3289945 DOI: 10.1016/0277-5379(88)90296-9 |
0.329 |
|
| 1988 |
Bélanger A, Giasson M, Couture J, Dupont A, Cusan L, Labrie F. Plasma levels of hydroxy-flutamide in patients with prostatic cancer receiving the combined hormonal therapy: an LHRH agonist and flutamide. The Prostate. 12: 79-84. PMID 3279409 DOI: 10.1002/Pros.2990120110 |
0.373 |
|
| 1988 |
Moorjani S, Dupont A, Labrie F, Lupien PJ, Gagné C, Brun D, Giguère M, Bélanger A, Cusan L. Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide. The Journal of Clinical Endocrinology and Metabolism. 66: 314-22. PMID 3276721 DOI: 10.1210/Jcem-66-2-314 |
0.332 |
|
| 1988 |
Brochu M, Bélanger A, Dupont A, Cusan L, Labrie F. Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate. Journal of Steroid Biochemistry. 28: 619-22. PMID 2961945 DOI: 10.1016/0022-4731(87)90388-8 |
0.372 |
|
| 1988 |
Brochu M, Bélanger A, Tremblay RR. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women. Fertility and Sterility. 48: 948-53. PMID 2960564 DOI: 10.1016/S0015-0282(16)59589-2 |
0.332 |
|
| 1988 |
Delarue C, Lihrmann I, Feuilloley M, Netchitaïlo P, Idres S, Leboulenger F, Bélanger A, Perroteau I, Vaudry H. In vitro study of frog adrenal function--IX. Evidence against the involvement of lipoxygenase metabolites in the control of steroid production. Journal of Steroid Biochemistry. 30: 461-4. PMID 2838699 DOI: 10.1016/0022-4731(88)90143-4 |
0.308 |
|
| 1988 |
Brochu M, Bélanger A. Comparative Study of Plasma Steroid and Steroid Glucuronide Levels in Normal Men and in Men With Benign Prostatic Hyperplasia Journal of Urology. 139: 884-885. DOI: 10.1016/S0022-5347(17)42697-8 |
0.357 |
|
| 1987 |
Labrie F, Dupont A, Bélanger A, Cusan L, Giguère M, Lacourcière Y, Luthy I, Bégin D, Labrie C, Simard J. Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience. Cancer Metastasis Reviews. 6: 615-36. PMID 3327635 DOI: 10.1007/Bf00047470 |
0.436 |
|
| 1987 |
Labrie F, Dupont A, Belanger A, Lachance R. Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonist. The Journal of Urology. 138: 804-6. PMID 3309363 DOI: 10.1016/S0022-5347(17)43380-5 |
0.373 |
|
| 1987 |
Moorjani S, Dupont A, Labrie F, Lupien PJ, Brun D, Gagné C, Giguère M, Bélanger A. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism: Clinical and Experimental. 36: 244-50. PMID 3102895 DOI: 10.1016/0026-0495(87)90183-1 |
0.302 |
|
| 1987 |
Brochu M, Belanger A. Increase in plasma steroid glucuronide levels in men from infancy to adulthood. The Journal of Clinical Endocrinology and Metabolism. 64: 1283-7. PMID 2952667 DOI: 10.1210/Jcem-64-6-1283 |
0.349 |
|
| 1986 |
Simard J, Luthy I, Guay J, Bélanger A, Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues Molecular and Cellular Endocrinology. 44: 261-270. PMID 3956856 DOI: 10.1016/0303-7207(86)90132-2 |
0.363 |
|
| 1986 |
Labrie F, Dupont A, Giguere M, Borsanyi JP, Belanger A, Lacourciere Y, Emond J, Monfette G. Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer. Journal of Steroid Biochemistry. 25: 877-83. PMID 3100871 DOI: 10.1016/0022-4731(86)90319-5 |
0.338 |
|
| 1986 |
Bélanger A, Brochu M, Cliche J. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. The Journal of Clinical Endocrinology and Metabolism. 62: 812-5. PMID 2937801 DOI: 10.1210/Jcem-62-5-812 |
0.329 |
|
| 1986 |
Parmar H, Phillips R, Lightman S, Edwards L, Labrie F, Dupont A, Bélanger A. LHRH ANALOGUES IN PROSTATIC CANCER The Lancet. 327: 445-446. DOI: 10.1016/S0140-6736(86)92404-9 |
0.335 |
|
| 1986 |
Labrie F, Dupont A, Belanger A, Poyet P, Giguere M, Lacourciere Y, Emond J, Monfette G, Borsanyi J, Urwin G. COMBINED TREATMENT WITH FLUTAMIDE AND SURGICAL OR MEDICAL (LHRH AGONIST) CASTRATION IN METASTATIC PROSTATIC CANCER The Lancet. 327: 48-49. DOI: 10.1016/S0140-6736(86)91935-5 |
0.321 |
|
| 1986 |
Bélanger A, Labrie F, Dupont A. Androgen levels in prostatic tissue of patients with carcinoma of the prostate treated with the combined therapy using an LHRH agonist and a pure antiandrogen European Journal of Cancer and Clinical Oncology. 22: 742. DOI: 10.1016/0277-5379(86)90276-2 |
0.366 |
|
| 1985 |
Tremblay Y, Bélanger A, Lacoste D, Giasson M, Labrie F. Selective inhibition of spermatogenesis in the presence of normal libido following combined treatment with an LHRH agonist and testosterone in the dog. Contraception. 30: 585-8. PMID 6397329 DOI: 10.1016/0010-7824(84)90008-8 |
0.401 |
|
| 1985 |
Carmichael R, Belanger A. Study of the direct effect of LHRH agonist on testicular 17-hydroxylase and 5 alpha-reductase activities in non-hypophysectomized adult rats treated with an anti-luteinizing hormone serum. Steroids. 43: 1-12. PMID 6395449 DOI: 10.1016/0039-128X(84)90054-0 |
0.373 |
|
| 1985 |
Tremblay Y, Bélanger A. Reversible inhibition of gonadal functions by a potent gonadotropin-releasing hormone agonist in adult dog. Contraception. 30: 483-97. PMID 6394207 DOI: 10.1016/0010-7824(84)90039-8 |
0.385 |
|
| 1985 |
Le Goff JM, Belanger A. Metabolism of tritiated C19 steroids by Shionogi mouse mammary tumors. Steroids. 44: 207-16. PMID 6242207 DOI: 10.1016/0039-128X(84)90002-3 |
0.341 |
|
| 1985 |
Tremblay Y, Belanger A. Effect of acute ACTH administration on plasma steroid levels in the dog. Steroids. 44: 57-66. PMID 6100341 DOI: 10.1016/S0039-128X(84)80016-1 |
0.323 |
|
| 1985 |
Khan I, Belanger A, Chen YD, Gibori G. Influence of high-density lipoprotein on estradiol stimulation of luteal steroidogenesis. Biology of Reproduction. 32: 96-104. PMID 3971012 DOI: 10.1095/Biolreprod32.1.96 |
0.337 |
|
| 1985 |
Labrie F, Dupont A, Belanger A, Lachance R, Giguere M. Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations. British Medical Journal (Clinical Research Ed.). 291: 369-70. PMID 3926197 DOI: 10.1016/S0022-5347(17)46100-3 |
0.324 |
|
| 1985 |
Tremblay Y, Bélanger A, Marchetti B. Specificity of the direct effect of an LHRH agonist on testicular 17-hydroxylase but not on 5 alpha-reductase activity in hypophysectomized adult rats. Molecular and Cellular Endocrinology. 40: 33-40. PMID 3922824 DOI: 10.1016/0303-7207(85)90155-8 |
0.417 |
|
| 1985 |
Labrie F, Dupont A, Belanger A, Giguere M, Lacoursiere Y, Emond J, Monfette G, Bergeron V. Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. Journal of Steroid Biochemistry. 23: 833-41. PMID 2934579 DOI: 10.1016/S0022-4731(85)80024-8 |
0.322 |
|
| 1985 |
Tremblay Y, Belanger A. Changes in plasma steroid levels after single administration of hCG or LHRH agonist analogue in dog and rat. Journal of Steroid Biochemistry. 22: 315-20. PMID 2581068 DOI: 10.1016/0022-4731(85)90432-7 |
0.339 |
|
| 1984 |
Raynaud JP, Bonne C, Moguilewsky M, Lefebvre FA, Bélanger A, Labrie F. The pure antiandrogen RU 23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review. The Prostate. 5: 299-311. PMID 6374639 DOI: 10.1002/Pros.2990050307 |
0.426 |
|
| 1984 |
Carmichael R, Belanger A, Caron S, Labrie F, Sairam MR. Comparative effects of LHRH agonist and ovine LH administration on testicular steroidogenesis in intact adult rat. Steroids. 40: 641-9. PMID 6318398 DOI: 10.1016/0039-128X(82)90004-6 |
0.33 |
|
| 1984 |
Tremblay Y, Bélanger A, Labrie F, Frenette G, Dubé JY, Tremblay RR. Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog. The Prostate. 5: 631-8. PMID 6208541 DOI: 10.1002/Pros.2990050609 |
0.426 |
|
| 1984 |
Dubé JY, Frenette G, Tremblay Y, Bélanger A, Tremblay RR. Single case report of prostate adenocarcinoma in a dog castrated three months previously. Morphological, biochemical, and endocrine determinations. The Prostate. 5: 495-501. PMID 6207517 DOI: 10.1002/Pros.2990050505 |
0.437 |
|
| 1984 |
Dubé JY, Frenette G, Tremblay RR, Tremblay Y, Bélanger A. Involution of spontaneous benign prostatic hyperplasia in the dog under the influence of chronic treatment with a LHRH agonist. The Prostate. 5: 417-23. PMID 6204326 DOI: 10.1002/Pros.2990050406 |
0.382 |
|
| 1984 |
Labrie F, Belanger A, Dupont A, Emond J, Lacoursiere Y, Monfette G. Combined Treatment With Lhrh Agonist And Pure Antiandrogen In Advanced Carcinoma Of Prostate The Lancet. 324: 1090. PMID 6150154 DOI: 10.1016/S0140-6736(84)91521-6 |
0.321 |
|
| 1984 |
Bélanger A, Dupont A, Labrie F. Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer. The Journal of Clinical Endocrinology and Metabolism. 59: 422-6. PMID 6086697 DOI: 10.1210/Jcem-59-3-422 |
0.392 |
|
| 1984 |
Lefebvre FA, Bélanger A, Pelletier G, Labrie F. Recovery of gonadal functions in the adult male rat following cessation of five-month daily treatment with an LHRH agonist. Journal of Andrology. 5: 181-92. PMID 6086556 DOI: 10.1002/J.1939-4640.1984.Tb02391.X |
0.355 |
|
| 1984 |
Raynaud J, Bonne C, Moguilewsky M, Lefebvre F, Bélanger A, Labrie F. The Pure Antiandrogen RU 23908 (Anandron), a Candidate of Choice for the Combined Antihormonal Treatment of Prostatic Cancer: A Review Journal of Urology. 132: 1065-1065. DOI: 10.1016/S0022-5347(17)50020-8 |
0.324 |
|
| 1983 |
Labrie F, Dupont A, Belanger A, Lacoursiere Y, Raynaud JP, Husson JM, Gareau J, Fazekas AT, Sandow J, Monfette G. New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens Prostate. 4: 579-594. PMID 6415630 DOI: 10.1002/Pros.2990040605 |
0.396 |
|
| 1983 |
Labrie F, Dupont A, Belanger A, Lefebvre FA, Cusan L, Monfette G, Laberge JG, Emond JP, raynaud JP, Husson JM, Fazekas ATA. New hormonal treatment in cancer of the prostate: Combined administration of an LHRH agonist and an antiandrogen Journal of Steroid Biochemistry. 19: 999-1007. PMID 6411995 DOI: 10.1016/0022-4731(83)90046-8 |
0.397 |
|
| 1983 |
Lefebvre FA, Séguin C, Bélanger A, Caron S, Sairam MR, Raynaud JP, Labrie F. Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat. The Prostate. 3: 569-78. PMID 6296803 DOI: 10.1002/Pros.2990030606 |
0.377 |
|
| 1982 |
Resko JA, Belanger A, Labrie F. Effects of chronic treatment with a potent luteinizing hormone releasing hormone agonist on serum luteinizing hormone and steroid levels in the male rhesus monkey. Biology of Reproduction. 26: 378-84. PMID 7044432 DOI: 10.1095/Biolreprod26.3.378 |
0.329 |
|
| 1982 |
Faure N, Labrie F, Lemay A, Bélanger A, Gourdeau Y, Laroche B, Robert G. Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men. Fertility and Sterility. 37: 416-24. PMID 6800852 DOI: 10.1016/S0015-0282(16)46107-8 |
0.39 |
|
| 1982 |
Cusan L, Pelletier G, Bélanger A, Séguin C, Kelly PA, Labrie F. Inhibition of Spermatogenesis and Steroidogenesis During Long-Term Treatment with hCG in the Rat Journal of Andrology. 3: 124-133. DOI: 10.1002/J.1939-4640.1982.Tb00656.X |
0.341 |
|
| 1981 |
Bélanger A, Cusan L, Caron S, Barden N, Dupont A. Ovarian progestins, androgens and estrogen throughout the 4-day estrous cycle in the rat. Biology of Reproduction. 24: 591-6. PMID 7195288 DOI: 10.1095/Biolreprod24.3.591 |
0.329 |
|
| 1981 |
Séguin C, Cusan L, Belanger A, Kelly PA, Labrie F, Raynaud J. Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent issues in the rat Molecular and Cellular Endocrinology. 21: 37-41. PMID 6259002 DOI: 10.1016/0303-7207(81)90028-9 |
0.388 |
|
| 1981 |
Carmichael R, Bélanger A, Cusan L, Séguin C, Caron S, Labrie F. Increased testicular 5 alpha-androstane-3 alpha, 17 beta-diol formation induced by treatment with [D-Ser (TBU) 6, des-Gly-NH2(10)] LHRH ethylamide in the rat. Steroids. 36: 383-91. PMID 6255633 DOI: 10.1016/0039-128X(80)90027-6 |
0.328 |
|
| 1981 |
Bélanger A, Auclair C, Séguin C, Caron S, Labrie F. Prolactin Stimulation of Testicular Steroid Biosynthesis in the Male Rat Journal of Andrology. 2: 80-86. DOI: 10.1002/J.1939-4640.1981.Tb00599.X |
0.352 |
|
| 1980 |
Bélanger A, Caron S, Picard V. Simultaneous radioimmunoassay of progestins, androgens and estrogens in rat testis. Journal of Steroid Biochemistry. 13: 185-90. PMID 7382493 DOI: 10.1016/0022-4731(80)90190-9 |
0.313 |
|
| 1980 |
Bélanger A, Labrie F, Lemay A, Caron S, Raynaud JP. Inhibitory effects of a single intranasal administration of [d-Ser(TBU)6, des-Gly-NH210]LHRK ethylamide, a potent LHRK agonist, on serum steroid levels in normal adult men Journal of Steroid Biochemistry. 13: 123-126. PMID 6770199 DOI: 10.1016/0022-4731(80)90182-X |
0.318 |
|
| 1980 |
Cusan L, Bélanger A, Séguin C, Labrie F. Impairment of pituitary and gonadal functions in alloxan-induced diabetic male rats. Molecular and Cellular Endocrinology. 18: 165-76. PMID 6248397 DOI: 10.1016/0303-7207(80)90063-5 |
0.316 |
|
| 1980 |
Belanger A, Auclair C, Ferland L, Caron S, Labrie F. Time-course of the effect of treatment with a potent LHRH agonist on testicular steroidogenesis and gonadotropin receptor levels in the adult rat. Journal of Steroid Biochemistry. 13: 191-6. PMID 6247573 DOI: 10.1016/0022-4731(80)90191-0 |
0.332 |
|
| 1980 |
LABRIE F, BÉLANGER A, CUSAN L, SEGUIN C, PELLETIER G, KELLY PA, REEVES JJ, LEFEBVRE F, LEMAY A, GOURDEAU Y, RAYNAUD J. Antifertility Effects of LHRH Agonists in the Male Journal of Andrology. 1: 209-228. DOI: 10.1002/J.1939-4640.1980.Tb00034.X |
0.374 |
|
| 1980 |
Pelletier G, Cusan GL, Bélanger A, Séguin C, Kelly PA, Labrie F. Further Studies on the Inhibitory Effect of [D‐A1a6, des‐Gly‐NH210]LHRH Ethylamide on Spermatogenesis and Steroidogenesis in the Rat: Reversibility and Effect of Androgen Administration Journal of Andrology. 1: 171-181. DOI: 10.1002/J.1939-4640.1980.Tb00029.X |
0.344 |
|
| 1979 |
Labrie F, Auclair C, Cusan L, Lemay A, Bélanger A, Kelly PA, Ferland L, Azadian-Boulanger G, Raynaud JP. Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and function. Advances in Experimental Medicine and Biology. 112: 687-93. PMID 223405 DOI: 10.1007/978-1-4684-3474-3_75 |
0.377 |
|
| 1974 |
Borgeat P, Labrie F, Drouin J, Bélanger A, Immer H, Sestanj K, Nelson V, Götz M, Schally AV, Coy DH, Coy EJ. Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone. Biochemical and Biophysical Research Communications. 56: 1052-9. PMID 4363638 DOI: 10.1016/S0006-291X(74)80295-0 |
0.312 |
|
| Show low-probability matches. |